Back to Search Start Over

Sofosbuvir-Based Antiviral Therapy Is Highly Effective In Recurrent Hepatitis C in Liver Transplant Recipients: Canadian Multicenter “Real-Life” Experience

Authors :
Faisal, Nabiha
Bilodeau, Marc
Aljudaibi, Bandar
Hirsch, Geri
Yoshida, Eric M.
Hussaini, Trana
Ghali, Maged P.
Congly, Stephen E.
Ma, Mang M.
Leonard, Jennifer
Cooper, Curtis
Peltekian, Kevork
Renner, Eberhard L.
Lilly, Leslie B.
Source :
Transplantation; May 2016, Vol. 100 Issue: 5 p1059-1065, 7p
Publication Year :
2016

Abstract

New HCV therapies result in sustained viral eradication (SVR) in most immune-competent and immune-compromised patients. In liver transplant recipients (LTR), data mainly come from clinical trials. This real-life Canadian multicenter study (n=120) confirms the excellent results (SVR 85%) in LTR started on sofosbuvir-based regimens.

Details

Language :
English
ISSN :
00411337 and 15346080
Volume :
100
Issue :
5
Database :
Supplemental Index
Journal :
Transplantation
Publication Type :
Periodical
Accession number :
ejs49256043
Full Text :
https://doi.org/10.1097/TP.0000000000001126